Health-Related Quality of life of patients with metastatic melanoma treated with tumor-infiltrating lymphocytes compared to ipilimumab in a randomized phase 3 trial
{{output}}
Backgroud: To assess health-related quality of life (HRQoL) in patients with metastatic melanoma treated with a tumor infiltrating lymphocyte investigational medicinal product (TIL-IMP) or ipilimumab (IPI) after failure of first-... ...
